A lipid has caught the eye of researchers looking to help treat glaucoma and other neurodegenerative diseases.
Jutley et al. discuss established glaucoma treatments, review promising new neuroprotective agents, and explore potential future treatments targeting the neurodenegerative processes in glaucoma.
A new retinal imaging technique is the first to identify individual cells; the new technique could aid earlier diagnosis and treatment of vision loss diseases such as glaucoma.
Researchers have developed a technique to derive retinal ganglion cells from human stem cells, which may be used as a model for future glaucoma research and treatment.